Heldo SA
1.7 FTEThe score of Heldo shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -44 % Total assets -40 % Headcount (avg FTE) -37 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Heldo's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 150,211 € | ||||
| Equity | 460,862 € | ||||
| Cash | 202,586 € | ||||
| EBITDA | 175,018 € | ||||
| Total assets | 621,357 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Aug 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 08 Aug 2022
Heldo's financial analysis
- Solvency74.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Heldo
Heldo's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0465.772.818
- VAT number
- BE0465772818
- Peppol
- Registered · 0208:0465772818 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Apr 1999
- Registered office
- 9420 Erpe-Mere
- Size
- Micro · 1.7 FTE
- Latest accounts
- 2025 · filed on 26 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Heldo (SA) has been based in Erpe-Mere since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 150,211 € and equity of 460,862 €; its revenue is not published. With 1.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 74.2%, above the median of its sector (44.2%).
Companies similar to Heldo
Companies in the same business, of comparable size and area, outside its group.
- Apotheek M Grillet-Louwaege Retail sale of pharmaceutical products Kortemark · balance sheet 621,387 €
- Pharmacie Solvay Retail sale of pharmaceutical products Herstal · balance sheet 621,411 €
- MVA Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 621,644 €
- Pharmadil Retail sale of pharmaceutical products Dilbeek · balance sheet 620,651 €
- Zichem Pharma Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet 622,406 €
- PH DE Linde Retail sale of pharmaceutical products Anderlecht · balance sheet 619,651 €
- Bioclin Retail sale of pharmaceutical products Ostend · balance sheet 623,434 €
- Hubert Pellegrin Retail sale of pharmaceutical products Uccle · balance sheet 623,769 €
Frequently asked questions about Heldo
What is the revenue of Heldo?
Heldo files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Heldo?
In Belgium, the VAT number is the company number prefixed with BE: BE0465772818 for Heldo, if the company is VAT-registered. Its company number (CBE) is 0465.772.818.
Where is the registered office of Heldo?
According to the CBE register, the registered office of Heldo is in 9420 Erpe-Mere.
What is the equity of Heldo?
At the close of the 2025 financial year, the equity of Heldo amounts to 460,862 €, a solvency of 74.2% of total assets.
How many people work at Heldo?
1.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Heldo?
The register lists 4 active mandates at Heldo. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Heldo
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →